Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024. In terms of the said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible…
What Sanofi files
- Others62
- Important15
- Updates9
- Board Meeting9
- Dividend/Bonus5
- Investor Meet1
Sanofi Consumer Healthcare India will hold its AGM. The company has set book closure and a Record Date for a Final Dividend payment, ensuring clarity on shareholder eligibility for the upcoming dividend.
Sanofi Consumer Healthcare India’s promoter group, Opal Bidco SAS, increased its stake by 10.87% through an off-market acquisition, raising promoter holding to over 1.39 crore shares. The deal is valued at more than INR 1,247 Cr, indicating stronger promoter control. No impact on operations or financials reported.
Opal Bidco SAS and Clayton, Dubilier & Rice Fund XII have received tenders for 41.83% of their open offer targeting a 26% stake in Sanofi Consumer Healthcare India, with 25.05 lakh shares tendered so far. Final share acceptance awaits validation and approvals. This move advances their consolidation of a significant...
Sanofi Consumer Healthcare India’s open offer to acquire a 26% stake has seen 40% of shares tendered, reflecting decent shareholder response. With 23.96 lakh shares submitted out of 59.88 lakh offered, final acceptance is pending validation. This signals a major ownership consolidation by Opal Bidco SAS and Clayton, Dubilier &...
Opal Bidco SAS and Clayton, Dubilier & Rice Fund XII have received tenders for 21.93 lakh shares (36.62% of their 26% open offer) in Sanofi Consumer Healthcare India, including a recent 3.62 lakh shares pending validation. The strong response highlights notable investor interest and points to a potential shift in...